Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services) EQUITY
neg -0.22
Today's Range: 76.79 - 78.09 | DGX Avg Daily Volume: 1,744,200
Last Update: 05/27/15 - 4:02 PM EDT
Volume: 2,064,848
YTD Performance: 15.39%
Open: $77.32
Previous Close: $77.38
52 Week Range: $56.27 - $89.00
Oustanding Shares: 143,636,295
Market Cap: 11,433,449,082
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 3 2
Moderate Buy 0 0 0 0
Hold 14 14 12 12
Moderate Sell 1 1 1 0
Strong Sell 2 3 3 3
Mean Rec. 3.02 3.12 3.02 3.08
Latest Dividend: 0.38
Latest Dividend Yield: 1.91%
Dividend Ex-Date: 07/06/15
Price Earnings Ratio: 22.81
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
22.81 22.60 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.83% 34.71% 33.41%
Revenue 4.00 -0.01 0.00
Net Income -33.00 0.16 0.05
EPS -31.20 0.30 0.09
Earnings for DGX:
Revenue 7.44B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.25 $1.27 $4.79 $5.10
Number of Analysts 12 11 13 15
High Estimate $1.29 $1.31 $4.89 $5.32
Low Estimate $1.20 $1.23 $4.73 $4.50
Prior Year $1.08 $1.10 $4.10 $4.79
Growth Rate (Year over Year) 15.51% 15.87% 16.87% 6.42%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Light volume precedes break for Memorial Day.
Major indices continue to show little movement as we approached the noon hour, although they have turned down in the last half hour. I can't recall such a flat week this year. Maybe everyone is already in the Hamptons and it is just the computers trading with each other.
Mar 27, 2015 | 7:59 AM EDT
Coverage of DGX was started with a Market Perform, JMP Securities said. Company is facing macro headwinds. 
Mar 25, 2015 | 7:22 AM EDT
DGX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on an $80 price target.
Here are healthcare stocks of all shares and sizes with strong charts.
Mar 03, 2015 | 5:49 AM EST
DGX was upgraded from Hold to Buy, Canaccord Genuity said. $82 price target. Company is cutting costs and should see higher test volume...
Feb 23, 2015 | 7:24 AM EST
DGX was downgraded to Underperform, Bank of America/Merrill Lynch said. $68 price target. Company appears to be growth slower than top ...

Get Some Positive Lab Results Real Money Pro($)

Try this options play for the sometimes volatile Bio-Reference Laboratories.
May 08, 2014 | 7:58 AM EDT
DGX was upgraded to Neutral from Underperform, Bank of America/Merrill Lynch said. $58 price target. Had positive meetings with managem...
Apr 14, 2014 | 8:19 AM EDT
Shares of DGX now seen reaching $62, according to Credit Suisse. Estimates also upped, given better reimbursement trends and the Solsta...

Columnist Conversations

Market recovers from yesterday's losses as investors go back into "risk on" mode. Concert Pharmaceuticals (CNC...
We added this name a few weeks back and now it is the talk of the buyout craze. No matter, because like CRM w...
Intel (INTC)'s pattern off the March corrective low (29.31) exhibits bullish form, which "warns us" that INTC ...
Thanks brotha appreciate the love! Keep an eye on $YUM -- funny feeling the Street could get behind the name a...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.